Clinical Trial Update: Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs

View source ↗

Summary

A clinical trial studying combinations of monoclonal antibodies with novel cancer drugs to overcome resistance to EGFR neutralization in non-small cell lung can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Non Small Cell Lung Cancer | Status: ACTIVE_NOT_RECRUITING